Announcement

Jeifer Biotech is excited to announce the launch of the ultra-pure spironolactone API, an advanced substance for precise endocrine and cardiovascular treatments.

This new type of product has a purity of 99.95%, ultra-low contaminants, enhanced stability, and meets the strict requirements of modern precision medicine and clinical applications in children and adults. Our GMP-certified facilities are currently in full operation, providing services to international pharmaceutical companies, contract development companies and healthcare distributors.